CENTESSA PHARMACEUTICALS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Centessa Pharmaceuticals plc – CNTA – QNT Press Release


NEW ORLEANS, Nov. 11, 2022 /PRNewswire/ — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr.remind investors that they have until November 28, 2022 to file lead plaintiff applications in a securities class action lawsuit against Centessa Pharmaceuticals plc (NASDAQ:CNTA), if they purchased or otherwise acquired the Company’s securities between May 28, 2021 and June 1, 2022inclusive (the “Class Period”) and/or purchased or otherwise acquired the Company’s American Depositary Shares (“ADSs”) pursuant to the Company’s May 2021 initial public offering (the “IPO”). This action is pending in the United States District Court for the Southern District of New York.

Full story available on Benzinga.com



Source link

Recommended For You

About the Author: News Center